75M.F - Wayland Group Corp.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.8590
+0.0500 (+6.18%)
As of 10:30AM CET. Market open.
Stock chart is not supported by your current browser
Previous Close0.8090
Open0.8680
Bid0.836 x 0
Ask0.855 x 0
Day's Range0.8510 - 0.8680
52 Week Range0.5740 - 2.9500
Volume3,420
Avg. Volume57,710
Market Cap172.609M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.265
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire22 hours ago

    REPEAT - International Cannabis and Wayland to Begin Integration of European Extraction and Distillation Processes; to Process 125,000 kg of CBD Flower  

    ICC International Cannabis Corp. (CSE:WRLD.U) (8K51.F) (WLDCF) ("ICC" or “International Cannabis” or the “Company”) is pleased to announce that further to the signed Letter of Intent (“LOI”) with Wayland Group Corp. (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) (see ICC news release dated January 15, 2019), the companies will begin integration of its extraction and distillation processes, in addition to finished dose manufacturing of CBD products for the European market.

  • GlobeNewswireyesterday

    International Cannabis and Wayland to Begin Integration of European Extraction and Distillation Processes; to Process 125,000 kg of CBD Flower  

    ICC International Cannabis Corp. (CSE:WRLD.U) (8K51.F) (WLDCF) ("ICC" or “International Cannabis” or the “Company”) is pleased to announce that further to the signed Letter of Intent (“LOI”) with Wayland Group Corp. (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) (see ICC news release dated January 15, 2019), the companies will begin integration of its extraction and distillation processes, in addition to finished dose manufacturing of CBD products for the European market.

  • GlobeNewswire7 days ago

    REPEAT - Wayland Group Enters into a Letter of Intent to Sell 49.9% of International Business to International Cannabis Corp.

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that, pursuant to the Company’s previously announced strategic review, it has entered into a Letter of Intent to sell 49.9% of the Company’s international portfolio of assets to International Cannabis Corp (“ICC”). Wayland will receive 300,000,000 shares of ICC that trade under the symbol WRLD.U on the Canadian Securities Exchange, at a deemed price of USD $0.43 per share (the “Issue Price”).

  • GlobeNewswire7 days ago

    REPEAT - International Cannabis to Acquire 49.9% of International Asset and Licence Portfolio From Wayland Group; Adds Licences in Germany, Switzerland, United Kingdom, Italy, Malta, Colombia, Argentina and Australia

    ICC International Cannabis Corp. (CSE:WRLD.U) (8K51.F) (KNHBF) ("ICC" or “International Cannabis” or the “Company”) is pleased to announce that it has entered into a Letter of Intent (the “LOI”), pursuant to which the companies will complete a Definitive Purchase Agreement (the “Definitive Agreement”) on or before March 1, 2019, to acquire 49.9% of Wayland Group Corp.’s (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) international assets and licence portfolio, as further described below (the “Transaction”). Wayland’s international assets and licences will be held in a subsidiary (the “International Subsidiary”), owned by Wayland and International Cannabis. The International Subsidiary will include key management from Wayland.

  • GlobeNewswire7 days ago

    International Cannabis to Acquire 49.9% of International Asset and Licence Portfolio From Wayland Group; Adds Licences in Germany, Switzerland, United Kingdom, Italy, Malta, Colombia, Argentina and Australia

    ICC International Cannabis Corp. (CSE:WRLD.U) (8K51.F) (KNHBF) ("ICC" or “International Cannabis” or the “Company”) is pleased to announce that it has entered into a Letter of Intent (the “LOI”), pursuant to which the companies will complete a Definitive Purchase Agreement (the “Definitive Agreement”) on or before March 1, 2019, to acquire 49.9% of Wayland Group Corp.’s (CSE:WAYL)(75M.F)(MRRCF) (“Wayland”) international assets and licence portfolio, as further described below (the “Transaction”). Wayland’s international assets and licences will be held in a subsidiary (the “International Subsidiary”), owned by Wayland and International Cannabis. The International Subsidiary will include key management from Wayland.

  • GlobeNewswire7 days ago

    Wayland Group Enters into a Letter of Intent to Sell 49.9% of International Business to International Cannabis Corp.

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that, pursuant to the Company’s previously announced strategic review, it has entered into a Letter of Intent to sell 49.9% of the Company’s international portfolio of assets to International Cannabis Corp (“ICC”). Wayland will receive 300,000,000 shares of ICC that trade under the symbol WRLD.U on the Canadian Securities Exchange, at a deemed price of USD $0.43 per share (the “Issue Price”).

  • GlobeNewswire14 days ago

    Maricann Group Inc. Completes Corporate Name Change to Wayland Group Corp.

    Maricann Group Inc. (CSE:WAYL) (75M.F) (MRRCF) (the “Company”) is pleased to announce that its previously announced proposed corporate name change to Wayland Group Corp. has now been completed. On September 24, 2018 the Company announced the proposed name change to better reflect its ongoing global expansion. The Company expects that its shares will begin trading on the Canadian Securities Exchange under the new Wayland Group Corp. name on January 10, 2019.

  • GlobeNewswire29 days ago

    Wayland Receives Additional Licensing from Health Canada

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that as of December 21, 2018 the Company has received additional licensing for seven (7) additional grow rooms from Health Canada, for phase one of its purpose-built cannabis production facility in Langton, ON. Over the next 4 weeks the Company will transition 21,900 vegetative plants into the newly licensed rooms, three of which will be used for one cycle of flower, after which they will be used to support a perpetual cycle of cultivation as vegetation rooms. “When the Company set out on this journey, one of our core objectives was to set the standard for high quality, large scale production of cannabis that consumers can trust.

  • GlobeNewswirelast month

    Wayland Group to Explore Strategic Alternatives to Maximize Shareholder Value Including the Spinout and/or European Listing of its International Assets

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”), a global, vertically integrated cultivator and processor of cannabis, today announced that its Board of Directors has initiated a process to explore a broad range of strategic alternatives, including, but not limited to assessing the potential spin-out and/or European listing of its international assets (the “International Assets”) in an effort to unlock the value of the Company’s vast international asset portfolio (a “Spinout Transaction”), as well as its underlying domestic Canadian assets. Any Spinout Transaction of the International Assets could include the Company’s European, Latin American, and Asia-Pacific operations.

  • GlobeNewswirelast month

    RavenQuest Announces Significant Supply Agreement With Wayland Group

    RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB  OTCQB: RVVQF  Frankfurt: 1IT) and Wayland Group (WAYL.CN) (75M.F) (MRRCF) (“Wayland”) are pleased to announce that they have entered into a supply agreement whereby Wayland will purchase up to 8,000 kg of dried flower cannabis from RavenQuest in 2019.  The total quantity will be shipped periodically throughout 2019 as product becomes available. As part of the supply agreement, Wayland will immediately make a one-time payment of $2 million to RavenQuest in anticipation of the first major shipment of cannabis flower in March 2019.  Pricing for the transaction is comparable with prevailing wholesale cannabis prices.

  • GlobeNewswirelast month

    Wayland Announces Significant Supply Agreement with RavenQuest BioMed

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) and RavenQuest BioMed Inc. (“RavenQuest”) are pleased to announce the companies have entered into a supply agreement whereby Wayland will purchase up to 8,000 kg of dried flower cannabis from RavenQuest in 2019. As part of the supply agreement, Wayland will make an immediate one-time payment of $2 million to RavenQuest in anticipation of the first major shipment of cannabis flower in March 2019.  Pricing for the transaction is comparable with prevailing wholesale cannabis prices.

  • GlobeNewswirelast month

    REPEAT - Wayland Group Announces Strategic Acquisition in Argentina

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to purchase 819 hectares of existing developed agriculture land in San Juan Province in Argentina. San Juan Province is ideal for cannabis cultivation due to the province’s climate and altitude. The presence of a stable economy and infrastructure to support business development is another contributing factor for the Company’s interest in the country.

  • GlobeNewswirelast month

    Wayland Group Announces Strategic Acquisition in Argentina

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to purchase 819 hectares of existing developed agriculture land in San Juan Province in Argentina. San Juan Province is ideal for cannabis cultivation due to the province’s climate and altitude. The presence of a stable economy and infrastructure to support business development is another contributing factor for the Company’s interest in the country.

  • GlobeNewswire2 months ago

    Wayland Enters the Asia-Pacific Market with Australian Acquisition

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce its expansion into Australia, through entering into an agreement to acquire 50.1% of Tropicann Pty Ltd. (“Tropicann”), a newly formed, privately owned Australian company located in Darwin, Northern Territory, to partner with industry leaders in Australia’s expanding cannabis industry. With this acquisition Wayland has positioned itself in the important and burgeoning Asia-Pacific market. “Globalization of cannabis continues, and we are present in relevant markets, with Asia-Pacific now added to our international footprint.

  • GlobeNewswire2 months ago

    Wayland Reports Q3 2018 Results

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) has reported its financial and operating results for the third quarter ended September 30, 2018 and has filed the full report on SEDAR. "Consistent with previous guidance, we reserved product for European export and the recreational market in Canada, which legalized cannabis for adult use on October 17th.

  • GlobeNewswire2 months ago

    REPEAT - Wayland Group Enters the United Kingdom

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to acquire 51% of UK based Theros Pharma Ltd. ("Theros"), an early stage company that has successfully imported cannabis to the UK for patients with a prescription for medical cannabis. This transaction enhances Wayland’s global growth strategy and will provide the Company with access to the UK market for sale and distribution of its products. Recent UK legislation allows for the prescription of cannabis from a medical specialist via a regular pharmacy model.

  • GlobeNewswire2 months ago

    Wayland Group Enters the United Kingdom

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to acquire 51% of UK based Theros Pharma Ltd. ("Theros"), an early stage company that has successfully imported cannabis to the UK for patients with a prescription for medical cannabis. This transaction enhances Wayland’s global growth strategy and will provide the Company with access to the UK market for sale and distribution of its products. Recent UK legislation allows for the prescription of cannabis from a medical specialist via a regular pharmacy model.

  • GlobeNewswire2 months ago

    Wayland Group Announces Appointment of General Counsel

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce the appointment of Matthew McLeod who will assume the role of General Counsel. The Company is pleased to welcome Matthew to the newly created role. Mr. McLeod was called to the Ontario bar in 2013 and the New York bar in 2014, holds a BEng and an MBA from the Royal Military College of Canada as well as a JD from Western University.

  • GlobeNewswire2 months ago

    REPEAT - Wayland Group Announces Definitive Agreement for Italian Joint Venture

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has completed a definitive joint venture agreement with CBD Italian Factory S.S., a company of Group San Martino for the production of high quality cannabis products in Italy. The joint venture will marry the best of both entities with world-leading technology by Rockwell Automation paired with existing infrastructure in Piedmont, Italy, which includes agricultural expertise and biogas electricity. This will allow the sustainable production of quality CBD and THC products from a naturally derived fuel source.

  • GlobeNewswire2 months ago

    Wayland Group Announces Definitive Agreement for Italian Joint Venture

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has completed a definitive joint venture agreement with CBD Italian Factory S.S., a company of Group San Martino for the production of high quality cannabis products in Italy. The joint venture will marry the best of both entities with world-leading technology by Rockwell Automation paired with existing infrastructure in Piedmont, Italy, which includes agricultural expertise and biogas electricity. This will allow the sustainable production of quality CBD and THC products from a naturally derived fuel source.

  • GlobeNewswire2 months ago

    Wayland Group Announces Closing of Over-Allotment Option for Additional Gross Proceeds of $7.5 Million

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that, further to its press release dated October 31, 2018 and in connection with its previously announced bought deal financing, it has issued an additional 4,552,500 Units (the “Units”) at a price of $1.65 per Unit (the “Offering Price”) for total gross proceeds of $7,511,625, pursuant to the exercise in full of the Underwriters’ over-allotment option. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements.

  • GlobeNewswire2 months ago

    REPEAT - Wayland Group Announces Changes to the Board

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to welcome Mr. Clay Horner and Mr. Rudolph (Rudi) Hilti to the board, which will strengthen and improve corporate governance, global strategy, finance, and M&A expertise. Additionally, Paul Pathak has now been appointed Chairman of the Board. Clay Horner is a principal of HBH Strategic Advisors which consults on significant   business and corporate matters for several large private equity firms and domestic and international corporations.

  • GlobeNewswire2 months ago

    Wayland Group Announces Changes to the Board

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to welcome Mr. Clay Horner and Mr. Rudolph (Rudi) Hilti to the board, which will strengthen and improve corporate governance, global strategy, finance, and M&A expertise. Additionally, Paul Pathak has now been appointed Chairman of the Board. Clay Horner is a principal of HBH Strategic Advisors which consults on significant   business and corporate matters for several large private equity firms and domestic and international corporations.

  • GlobeNewswire3 months ago

    REPEAT - Wayland Group Enters into Agreement to Expand Global Footprint with Acquisition in Colombia

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company) is pleased to announce that the Company has entered the South American market through a transaction in Colombia. Wayland has entered into a definitive agreement to acquire 100% of the outstanding shares of Colma Pharmaceutical SAS (“Colma”), a licenced producer of THC cannabis in Colombia, holding four licences for cultivation and processing on a leased premise in Ibague, Colombia. Under the terms of the agreement, Wayland will issue 11 million common shares as consideration for the shares of Colma with shares being issued at a deemed price of CAD$2.00 per share.